Therapeutic Area Standards

Alzheimer's | Asthma | Cardiovascular | Chronic Hepatitis C | COPD | Diabetes | Diabetes ADaM Supplement | Dyslipidemia | Influenza | Multiple Sclerosis | Pain | Parkinson's Disease | Polycystic Kidney Disease | QT Studies | Schizophrenia Traumatic Brain Injury | Tuberculosis | Virology

 

CFAST Therapeutic Area Standards Program

The Coalition for Accelerating Standards and Therapies (CFAST), a joint initiative of CDISC and the Critical Path Institute (C-Path), was launched to accelerate clinical research and medical product development by facilitating the establishment and maintenance of data standards, tools and methods for conducting research in therapeutic areas important to public health.

 

CFAST partners include TransCelerate BioPharma Inc. (TCB), the U.S. Food and Drug Administration (FDA), and the National Cancer Institute – Enterprise Vocabulary Service (NCI-EVS), with participation and input from additional organizations. For more information on the CFAST relationship, please visit the CFAST Collaboration page

 

Current CFAST Project Status (Click on a project name to view description)

 

CFAST Program Overview

 

 

 

Subscribe to RSS - Therapeutic Area Standards